Corton Capital Inc. Corcept Therapeutics Inc Transaction History

Corton Capital Inc.

  • $196 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $119,334 - $185,261
-5,373 Reduced 31.5%
11,682 $379,000
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $173,209 - $225,419
8,209 Added 92.8%
17,055 $429,000
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $219,557 - $290,856
8,846 New
8,846 $287,000

Others Institutions Holding CORT

# of Institutions
368
Shares Held
86.8M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.29B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email